Elenco degli articoli con argomento «psoriasi»
Dermatologia27 giu 2022
Bullous pemphigoid induced by biologic drugs
Several therapies for psoriasis have been described as triggers of biologic-induced bullous pemphigoid (BIBP).
27 giu 2022
Generalized pustular psoriasis
Generalized pustular psoriasis (GPP) is a rare yet severe variant of psoriasis
08 giu 2022
Il prurito nei pazienti oncologici
Questo foglio illustrativo ha lo scopo di informarla sul prurito indotto dai farmaci antitumorali.
23 mag 2022
Pathophysiology of Generalized Pustular Psoriasis
Generalized pustular psoriasis (GPP) is a rare, severe form of pustular psoriasis
18 apr 2022
Effectiveness and Safety of Adalimumab, Etanercept and Ustekinumab
Biological therapies are valuable treatments for severe psoriasis. Children aged under 12 years are underrepresented in therapeutic trials for these drugs.
11 apr 2022
Prevalence and characterization of treatment-refractory psoriasis
Treatment with biologics often leads to clearance of psoriasis.
04 apr 2022
Italian adaptation of EuroGuiDerm guideline
SIDeMaST contributed to the development of the present guideline on the systemic treatment of chronic plaque psoriasis.
14 mar 2022
Secukinumab Drug Survival in Psoriasis and Psoriatic Arthritis Patients
Secukinumab effectiveness has been demonstrated in both psoriasis (PsO) and psoriatic arthritis (PsA)
14 feb 2022
Biologic therapies associated with development of palmoplantar pustulosis
Palmoplantar pustulosis (PPP) and palmoplantar pustular psoriasis (PPPP) are chronic inflammatory skin conditions characterized by eruptions of sterile pustules on the palms and/or soles.
07 feb 2022
Prevalence of Candida species in Psoriasis
Psoriasis patients are more frequently colonised with Candida species.
20 dic 2021
Apremilast for the treatment of palmo-plantar non-pustular psoriasis
Palmoplantar psoriasis (PP) is a type of psoriasis that involves the skin of the palms and soles and can present as hyperkeratotic
20 dic 2021
Efficacy and Safety of Different Formulations of Calcipotriol/Betamethasone Dipropionate in Psoriasis
Preparations containing calcipotriol combined with betamethasone dipropionate (in the forms of ointment, gel, and foam) are available for the topical treatment of psoriasis
06 dic 2021
The promise and challenges of cell therapy for psoriasis
The management of moderate-to-severe psoriasis has been transformed by the introduction of biological therapies.
22 nov 2021
Interplay Between Skin Microbiota Dysbiosis and the Host Immune System in Psoriasis
Psoriasis is a multifactorial immune-mediated disease.
15 nov 2021
The burden of psoriasis on patient's caregivers
The burden of psoriasis on patient's caregivers
14 ott 2021
Psoriasi e dermatite atopica indicazioni dei dermatologi
Le nuove chances terapeutiche per eliminare le lesioni cutanee e mitigare il prurito, al centro della seconda giornata di lavori del Congresso della Società Italiana di Dermatologia e delle Malattie Sessualmente Trasmesse.
11 ott 2021
Tildrakizumab for treatment of moderate to severe psoriasis
IntroductionTildrakizumab is a monoclonal antibody that targets the p19 subunit of IL-23, a crucial cytokine for Th17 cells.
06 set 2021
Psoriasis exacerbation after COVID-19 vaccination
Psoriasis exacerbation after COVID-19 vaccination
06 set 2021
Drug Survival of IL-12/23, IL-17 and IL-23 Inhibitors for Psoriasis Treatment
Drug survival analysis of biologic agents in psoriasis is of extreme importance
06 set 2021
Predictive factors of lack of response to adalimumab among bio-naive patients
Efficacy of anti-TNF-a agents seems inferior to IL-17 and IL-23 inhibitors.